down arrow

Nu Skin Enterprises, Inc.

  • Market Cap: Micro Cap
  • Industry: FMCG
  • ISIN: US67018T1051
USD
9.81
-0.17 (-1.7%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

9.7910.10

52 Week

5.3214.62
Valuation
Technical
Day's Volume

CASH

369.98 k

Shareholding (Mar 2025)

FII

8.97%

Held by 107 FIIs

DII

48.32%

Held by 48 DIIs

Promoter

0.02%

How big is Nu Skin Enterprises, Inc.?

22-Jun-2025

As of Jun 18, Nu Skin Enterprises, Inc. has a market capitalization of 698.62 million and reported net sales of 1,679.26 million with a net loss of 38.54 million over the latest four quarters. Shareholder's funds are at 651.46 million, and total assets amount to 1,468.91 million.

As of Jun 18, Nu Skin Enterprises, Inc. has a market capitalization of 698.62 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 1,679.26 million, while the sum of net profit for the same period is a loss of 38.54 million.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds at 651.46 million and total assets at 1,468.91 million.

Read More

What does Nu Skin Enterprises, Inc. do?

22-Jun-2025

Nu Skin Enterprises, Inc. is a direct selling company that develops and distributes personal care products and nutritional supplements. As of March 2025, it reported net sales of $364 million and a market cap of $698.62 million.

Overview:<BR>Nu Skin Enterprises, Inc. is a direct selling company that develops and distributes personal care products and nutritional supplements, operating within the FMCG industry and classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 364 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 108 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 698.62 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 4.00 <BR>Dividend Yield: 1.71% <BR>Debt Equity: 0.03 <BR>Return on Equity: 23.44% <BR>Price to Book: 0.93 <BR><BR>Contact Details:<BR>Address: 75 W Center St, PROVO UT: 84601-4432 <BR>Tel: 1 801 3451000 <BR>Website: https://www.nuskin.com/

Read More

Who are in the management team of Nu Skin Enterprises, Inc.?

22-Jun-2025

As of March 2022, the management team of Nu Skin Enterprises, Inc. includes Executive Chairman Steven Lund, CEO Ritch Wood, Lead Independent Director Daniel Campbell, and Independent Directors Andrew Lipman, Laura Nathanson, Thomas Pisano, and Zheqing Shen. They are responsible for the company's strategic direction and governance.

As of March 2022, the management team of Nu Skin Enterprises, Inc. includes the following individuals:<BR><BR>- Mr. Steven Lund, who serves as the Executive Chairman of the Board.<BR>- Mr. Ritch Wood, who is the Chief Executive Officer and a Director.<BR>- Mr. Daniel Campbell, who holds the position of Lead Independent Director.<BR>- Mr. Andrew Lipman, who is an Independent Director.<BR>- Ms. Laura Nathanson, who is also an Independent Director.<BR>- Mr. Thomas Pisano, who serves as an Independent Director.<BR>- Mr. Zheqing Shen, who is another Independent Director.<BR><BR>This team plays a crucial role in guiding the company's strategic direction and governance.

Read More

Is Nu Skin Enterprises, Inc. overvalued or undervalued?

20-Sep-2025

As of August 7, 2025, Nu Skin Enterprises, Inc. is considered an attractive investment due to its undervalued metrics, including a P/E ratio of 4, an EV to EBITDA ratio of 6.39, a Price to Book Value of 0.95, and a high return on equity of 23.44%, alongside strong market performance that significantly outpaces the S&P 500.

As of 7 August 2025, the valuation grade for Nu Skin Enterprises, Inc. has moved from risky to attractive. The company appears undervalued, as indicated by its P/E ratio of 4, which is significantly lower than the peer average of 5.47, and its EV to EBITDA ratio of 6.39 compared to the peer average of 8.64. Additionally, the Price to Book Value stands at 0.95, suggesting that the stock is trading below its book value.<BR><BR>In comparison to its peers, Nu Skin's return on equity (ROE) is notably high at 23.44%, which further supports its attractive valuation. The company has outperformed the S&P 500 in recent periods, with a year-to-date return of 78.81% compared to the S&P 500's 12.22%, and a one-year return of 68.31% against 17.14% for the index. This performance reinforces the notion that Nu Skin is undervalued relative to its strong financial metrics and market performance.

Read More

Is Nu Skin Enterprises, Inc. technically bullish or bearish?

20-Sep-2025

As of August 11, 2025, Nu Skin Enterprises, Inc. shows a bullish technical trend supported by positive MACD and Bollinger Bands, despite a mildly bearish signal from the weekly Dow Theory, and has outperformed the S&P 500 with a year-to-date return of 78.81%.

As of 11 August 2025, the technical trend for Nu Skin Enterprises, Inc. has changed from mildly bullish to bullish. The weekly MACD and Bollinger Bands are both bullish, supporting the positive stance, while the daily moving averages also indicate bullish momentum. However, the weekly Dow Theory shows a mildly bearish signal, suggesting some caution. The stock has significantly outperformed the S&P 500 year-to-date with a return of 78.81% compared to 12.22%. Overall, the current technical stance is bullish, with strong indicators driving this outlook.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROCE of 16.78%

 
2

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.54 times

 
3

The company declared positive results in Mar'25 after negative results in Dec'24

4

With ROCE of 6.42%, it has a risky valuation with a 0.95 Enterprise value to Capital Employed

5

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

FMCG

stock-summary
Market cap

USD 1,036 Million (Micro Cap)

stock-summary
P/E

4.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.15%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

24.02%

stock-summary
Price to Book

1.31

Revenue and Profits:
Net Sales:
386 Million
(Quarterly Results - Jun 2025)
Net Profit:
21 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-20.24%
0%
-20.24%
6 Months
24.49%
0%
24.49%
1 Year
25.93%
0%
25.93%
2 Years
-44.32%
0%
-44.32%
3 Years
-76.75%
0%
-76.75%
4 Years
-77.92%
0%
-77.92%
5 Years
-81.36%
0%
-81.36%

Nu Skin Enterprises, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Nu Skin Enterprises, Inc. Experiences Revision in Stock Evaluation Amid Mixed Financial Metrics

Nu Skin Enterprises, Inc. Experiences Revision in Stock Evaluation Amid Mixed Financial Metrics

Nu Skin Enterprises, Inc. has adjusted its valuation, reporting a P/E ratio of 4 and a price-to-book value of 0.95, indicating a favorable asset valuation. Despite a strong year-to-date performance of 32.37%, the company has faced significant long-term challenges, with three- and five-year returns showing substantial declines.

Read More
Nu Skin Enterprises Hits New 52-Week High at $14.62

Nu Skin Enterprises Hits New 52-Week High at $14.62

Nu Skin Enterprises, Inc. achieved a new 52-week high of USD 14.62 on September 23, 2025, marking a recovery for the microcap company in the FMCG sector. Despite a challenging year, its market capitalization is USD 1,036 million, with a P/E ratio of 4.00 and a return on equity of 24.02%.

Read More
Nu Skin Enterprises Hits New 52-Week High at $13.17

Nu Skin Enterprises Hits New 52-Week High at $13.17

Nu Skin Enterprises, Inc. achieved a new 52-week high of USD 13.17 on September 22, 2025, signaling a recovery for the microcap company in the FMCG sector. With a market cap of approximately USD 1,036 million, a P/E ratio of 4.00, and a return on equity of 24.02%, the company shows strong performance metrics.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-6.73%
EBIT Growth (5y)
-23.61%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0.54
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
1.56
Tax Ratio
7.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
90.32%
ROCE (avg)
16.78%
ROE (avg)
17.52%
Valuation key factors
Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
0.95
EV to EBIT
14.76
EV to EBITDA
6.39
EV to Capital Employed
0.95
EV to Sales
0.44
PEG Ratio
NA
Dividend Yield
1.68%
ROCE (Latest)
6.42%
ROE (Latest)
23.44%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 58 Schemes (42.6%)

Foreign Institutions

Held by 107 Foreign Institutions (8.97%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 5.93% vs -18.20% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -80.37% vs 397.78% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "386.10",
          "val2": "364.50",
          "chgp": "5.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "43.80",
          "val2": "29.40",
          "chgp": "48.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.50",
          "val2": "3.30",
          "chgp": "-24.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-53.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "21.10",
          "val2": "107.50",
          "chgp": "-80.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "79.70%",
          "val2": "41.70%",
          "chgp": "3.80%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -12.04% vs -11.53% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1,804.65% vs -91.79% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,732.10",
          "val2": "1,969.10",
          "chgp": "-12.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "120.60",
          "val2": "137.70",
          "chgp": "-12.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "26.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-202.40",
          "val2": "-19.80",
          "chgp": "-922.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-146.60",
          "val2": "8.60",
          "chgp": "-1,804.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.30%",
          "val2": "34.60%",
          "chgp": "-0.53%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
386.10
364.50
5.93%
Operating Profit (PBDIT) excl Other Income
43.80
29.40
48.98%
Interest
2.50
3.30
-24.24%
Exceptional Items
0.00
-53.20
100.00%
Consolidate Net Profit
21.10
107.50
-80.37%
Operating Profit Margin (Excl OI)
79.70%
41.70%
3.80%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 5.93% vs -18.20% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -80.37% vs 397.78% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,732.10
1,969.10
-12.04%
Operating Profit (PBDIT) excl Other Income
120.60
137.70
-12.42%
Interest
26.40
0.00
Exceptional Items
-202.40
-19.80
-922.22%
Consolidate Net Profit
-146.60
8.60
-1,804.65%
Operating Profit Margin (Excl OI)
29.30%
34.60%
-0.53%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -12.04% vs -11.53% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -1,804.65% vs -91.79% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Nu Skin Enterprises, Inc. stock-summary
stock-summary
Nu Skin Enterprises, Inc.
FMCG
Nu Skin Enterprises, Inc. is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system. The Pharmanex product line includes ageLOC Youth nutritional supplement, ageLOC TR90 weight management and body shaping system, and LifePak nutritional supplements. The Company has operations in various geographic regions, including Greater China, North Asia, Americas, South Asia/Pacific, and Europe, the Middle East and Africa (EMEA). It is focused on offering ageLOC Youth nutritional supplement and ageLOC Me personalized skin care system. The Company also offers household products and technology services.
Company Coordinates stock-summary
Company Details
75 W Center St , PROVO UT : 84601-4432
stock-summary
Tel: 1 801 3451000
stock-summary
https://www.nuskin.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."